Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Bavarian Nordic
company
About
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention.
- 251 - 500
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- €50M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1994
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€50M
Bavarian Nordic has raised a total of
€50M
in funding over 2 rounds. Their latest funding was raised on
May 12, 2015 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2015 | Post-IPO Debt | €50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Bavarian Nordic is funded by 1 investors.
European Investment Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
European Investment Bank
|
— | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
